Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 1,944,466
- Share change
- -7,351
- Total reported value
- $3,341,879
- Price per share
- $1.72
- Number of holders
- 18
- Value change
- -$12,369
- Number of buys
- 7
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,275,000
|
$4,794,000 | — | 27 Jun 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3%
|
1,351,275
|
$2,297,168 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
252,060
|
$428,502 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
114,097
|
$193,965 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
76,732
|
$130,473 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.16%
|
72,669
|
$123,537 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
17,416
|
$29,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
16,519
|
$28,082 | — | 31 Mar 2025 | |
| Apella Capital, LLC |
13F
|
Company |
0.05%
|
20,625
|
$27,638 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
12,915
|
$21,956 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
11,004
|
$18,707 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,643
|
$4,493 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,938
|
$3,295 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,621
|
$2,756 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
100
|
$170 | — | 31 Mar 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
100
|
$155 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
62
|
$105 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
53
|
$90 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
46
|
$78 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
25
|
$43 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
17
|
$29 | — | 31 Mar 2025 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
12
|
$20 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
605,230
|
— | — | 11 Aug 2022 | |
| Jeryl L. Hilleman |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 27 Sep 2023 | |
| William F. Doyle |
3/4/5
|
Director |
—
class O/S missing
|
2,500
|
— | — | 10 Jun 2022 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q2 2025
As of 30 Jun 2025,
Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,944,466 shares.
The largest 10 holders included
FEDERATED HERMES, INC., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Apella Capital, LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, ADAR1 Capital Management, LLC, and MORGAN STANLEY.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
19
Q2 2025 holders
18
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.